← Back to Patent Explorer
US4396550A Expired / Lapsed US ⏱️ 0.0 years remaining

Dibenz [b,e] oxepin derivatives

Assignee: KH Neochem Co Ltd
•
Filing: 1981-04-21
•
Granted: 1983-08-02
•
Expires: 2001-04-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel dibenz [b,e] oxepin derivatives represented by the general formula: <IMAGE> (Ia) wherein R11 represents an alkyl group containing 1 to 5 carbon atoms, an alkoxy group containing 1 to 5 carbon atoms, a halogen atom, a cyclohexyl group or a phenyl group; and R21 represents <IMAGE> (1) wherein X represents a hydrogen atom, a hydroxy group, an amino group or a substituted aralkyl group containing 7 to 20 carbon atoms, and n represents 0 or an integer of 1 to 3 <IMAGE> (2) or (3) -NH-(CH2)n-Y, wherein Y represents an alkylamino group containing 1 to 5 carbon atoms, an aralkyl group containing 7 to 20 carbon atoms, a substituted aralkyl group, an aralkyloxy group containing 7 to 20 carbon atoms, an aralkylamino group containing 7 to 20 carbon atoms, a heterocyclic ring or a substituted heterocyclic ring, and n has the same meaning as defined before; provided that when R11 represents an alkyl group, an alkoxy group or a halogen atom, X does not represent a hydrogen atom; and the pharmaceutically acceptable acid addition salts thereof. Also disclosed are pharmaceutical compositions comprising a pharmaceutical carrier and, as an active ingredient, an effective amount of a dibenz [b,e] oxepin derivative represented by the following general formula: <IMAGE> (I) wherein R1 represents an alkyl group containing 1 to 5 carbon atoms, an alkoxy group containing 1 to 5 carbon atoms, a halogen atom, a cyclohexyl group or a phenyl group; and R2 represents <IMAGE> (1) wherein X represents a hydrogen atom, a hydroxy group, an amino group or a substituted aralkyl group containing 7 to 20 carbon atoms, and n has the same meaning as defined before <IMAGE> (2) or (3) -NH-(CH2)n-Y, wherein Y and n have the same meaning as defined above; and the pharmaceutically acceptable acid addition salts thereof. Compound I, represented by the general formula (I), has antichlolinergic, antihistaminergic, antiasthmatic and antiplatelet aggregation activities, and is therefore useful as a sposmolysant, an antihistaminic, an antiasthmatic agent and as a medicament for cardiovascular or cerebrovascular diseases, respectively.

Inventors

  • 👤 Hiroshi Takizawa
  • 👤 Osamu Morita
  • 👤 Yoshimasa Oiji
  • 👤 Tamotsu Hashimoto

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 22:55
CPC Classifications
C; C07; C07D; C07D491/00; C07D491/02; C07D491/10; C07D313/00; C07D313/02; C07D313/06; C07D313/10; C07D313/12; C07D453/00; C07D453/02

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 63 words
A dibenz[b,e]oxepin compound represented by the formula: ##STR59## wherein R 11 represents an alkyl group having 1 to 5 carbon atoms or a cyclohexyl group; and R 21 represents --NH--(CH 2 ) n --Y, wherein Y represents an alkylamino group having 1 to 5 carbon atoms and n represents an integer of 1 to 3; and the pharmaceutically acceptable acid addition salts thereof.
Claim 2
Dependent Claim 63 words
A dibenz[b,e]oxepin compound represented by the formula: ##STR59## wherein R 11 represents an alkyl group having 1 to 5 carbon atoms or a cyclohexyl group; and R 21 represents --NH--(CH 2 ) n --Y, wherein Y represents an alkylamino group having 1 to 5 carbon atoms and n represents an integer of 1 to 3; and the pharmaceutically acceptable acid addition salts thereof.
Claim 3
Dependent Claim 19 words
A dibenz[b,e]oxepin compound of claim 1 wherein R 11 represents an alkyl group containing 1 to 5 carbon atoms.
Claim 4
Dependent Claim 24 words
A dibenz[b,e]oxepin compound of claim 2 wherein the alkyl group represents a methyl group, an ethyl group, a propyl group or a butyl group.
Claim 5
Dependent Claim 18 words
A dibenz[b,e]oxepin compound of claim 3 wherein the alkyl group represents a methyl group or an ethyl group.
Claim 6
Dependent Claim 13 words
A dibenz[b,e]oxepin compound of claim 1 wherein R 11 represents a cyclohexyl group.
Claim 7
Dependent Claim 34 words
A dibenz[b,e]oxepin compound of claim 1 wherein Y represents a methylamino group, an ethylamino group, a propylamino group, a dimethylamino group or a diethylamino group, and n has the same meaning as defined before.
Claim 8
Dependent Claim 25 words
A dibenz[b,e]oxepin compound of claim 6 wherein Y represents a dimethylamino group or a diethylamino group, and n has the same meaning as defined before.
Claim 9
Dependent Claim 1 words
2-ethyl-11-{2-(diethylamino)ethyl}amino-6,11-dihydrodibenz[b,e]oxepin.
Claim 10
Dependent Claim 1 words
2-ethyl-11-{2-(diethylamino)ethyl}amino-6,11-dihydrodibenz[b,e]oxepin.
Claim 11
Dependent Claim 1 words
2-methyl-11-{3-diethylamino)propyl}amino-6,11-dihydrodibenz[b,e]oxepin.
Claim 12
Dependent Claim 1 words
2-methyl-11-{3-diethylamino)propyl}amino-6,11-dihydrodibenz[b,e]oxepin.
Claim 13
Dependent Claim 1 words
2-ethyl-11-{3-(dimethylamino)propyl}amino-6,11-dihydrodibenz[b,e]oxepin
Claim 14
Dependent Claim 1 words
2-ethyl-11-{3-(dimethylamino)propyl}amino-6,11-dihydrodibenz[b,e]oxepin
Claim 15
Dependent Claim 1 words
2-ethyl-11-{2-(dimethylamino)ethyl}amino-6,11-dihydrodibenz[b,e]oxepin.
Claim 16
Dependent Claim 1 words
2-ethyl-11-{2-(dimethylamino)ethyl}amino-6,11-dihydrodibenz[b,e]oxepin.
Claim 17
Dependent Claim 1 words
2-cyclohexyl-11-{2-(diethylamino)ethyl}amino-6,11-dihydrodibenz[b,e]oxepin.
Claim 18
Dependent Claim 1 words
2-cyclohexyl-11-{2-(diethylamino)ethyl}amino-6,11-dihydrodibenz[b,e]oxepin.

References Cited (Backward Citations)

US3509176A Cited
US3458516A Cited
US3872102A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-08-01 1987-01-31 1987-08-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-08-01 1991-01-31 1991-08-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-08-01 1995-01-31 1995-08-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag